The BBC's new director-general has told MPs the current TV licence funding model is holding the broadcaster back as ministers ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Jonathan Munro, the interim chief executive of BBC News, has told staff that the broadcaster's news channel should increasingly focus on audiences outside the UK.
Pirtobrutinib plus venetoclax-rituximab reduced progression/death risk vs venetoclax-rituximab alone in R/R CLL/SLL, with higher undetectable MRD rates at 10–6. Head-to-head FLT3 inhibition in ...
A newly released report from the Advertising Research Foundation (ARF) concludes that the line between linear and streaming television is becoming increasingly difficult to draw. According to the new ...
Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today shared positive updated results from inMMyCAR, the ongoing first-in-human Phase 1 study of ...
Lisocabtagene maraleucel (liso-cel) as first-line (1L) therapy for transplant-ineligible patients (pt) with primary central nervous system lymphoma (PCNSL): The CAROLYN study. This is an ASCO Meeting ...
When you order a new broadcast transmitter, one of the first questions will be about power. Is it single-phase or three-phase alternating current? If single-phase, it is 208 or 240 volts? If it is ...
Optimism rose for what could be the first CAR T therapy in autoimmune disease as Kyverna Therapeutics Inc. made public a positive primary analysis from its registrational trial, KYSA-8, of ...
MIT researchers built a 3D printer that can produce a fully functioning electric linear motor in about three hours for 50 cents in materials. Linear motors are typically used in optical systems and ...
As the US ponders legislation to preserve AM radio access in cars, the UK government is preparing to debate whether FM broadcasting should be phased out in the 2030s, as digital listening now accounts ...
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the launch of ResQ215B, a Phase 2 clinical study evaluating a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results